Pharmaceutical Executive-12-01-2012
Pharmaceutical Executive
Tax and budget decisions will shape the healthcare market and drug research and regulation.
Pharmaceutical Executive
At two years and counting, what's the secret of success in negotiating pricing under the new AMNOG legislation?
Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.
Pharmaceutical Executive
Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.
Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.
Advertisement
Advertisement
Trending on PharmExec
1
Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts
2
Roundup: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy, Enodia Therapeutics Enters Collaboration and License Agreement to Develop Sec61-Targeting Small Molecules
3
The Bottlenecks That Slow Manufacturer Response to Increased Demand for Production
4
Pharmaceutical Executive Daily: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy with Roche
5